A novel, potent series of indole analogs were recently developed as MR antagonists, culminating in 14. This compound represents the first MR antagonist in this class of molecules, exhibiting picomolar binding affinity and in vivo blood pressure lowering at pharmaceutically relevant doses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/jm701186z | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!